Tissue-specific immune memory has become a central focus in immunology, drawing attention to the distinct roles of tissue-resident memory lymphocytes, their ...

Faron Pharma’s bexmarilimab demonstrates immune-activating and drug-sensitizing potential in myeloid malignancies: Turku, Finland Wednesday, May 28, 2025, 16:00 Hrs [IST] Faron ...

TURKU, FI / ACCESS Newswire / May 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - New preclinical data published in Scientific Reports confirms CLEVER-1 inhibition by Bexmarilimab increases ...

A National Institutes of Health (NIH)-funded study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg ...

A study by researchers from Johns Hopkins Medicine, the Johns Hopkins Bloomberg School of Public Health and The Johns Hopkins ...

Changes in blood are detectable at age 50 and universal by 60, paving the way for spotting early signs of unhealthy aging.

A study in the journal Nature explains how age reshapes the blood system. In both humans and mice, a few stem cells, or ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

Single-cell RNA sequencing (scRNA-seq ... reflected both early developmental blocks and lineage-biased differentiation toward myeloid, lymphoid, and erythroid fates. Analysis showed that primitive ...

a transporter of IgG across polarized cells such as epithelia, a protector of IgG and albumin from catabolism, and a regulator of cellular pathways of immunity associated with myeloid cells.